Susquehanna International Group’s Integra LifeSciences IART Stock Holding History

Susquehanna International Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$243K	Buy	+25,745	New	+$283K	﹤0.01%	11332
2025 Q4	–	Sell	-38,434	Closed	-$551K	–	12892
2025 Q3	$551K	Sell	38,434 -47,200	-55%	-$647K	﹤0.01%	8735
2025 Q2	$1.05M	Sell	85,634 -8,127	-9%	-$118K	﹤0.01%	7290
2025 Q1	$2.06M	Buy	93,761 +42,965	+85%	+$1.01M	﹤0.01%	5470
2024 Q4	$1.15M	Buy	50,796 +2,423	+5%	+$52.9K	﹤0.01%	6607
2024 Q3	$879K	Buy	48,373 +35,706	+282%	+$828K	﹤0.01%	7107
2024 Q2	$369K	Sell	12,667 -25,931	-67%	-$769K	﹤0.01%	8995
2024 Q1	$1.37M	Buy	38,598 +25,357	+192%	+$1.01M	﹤0.01%	6206
2023 Q4	$577K	Buy	+13,241	New	+$521K	﹤0.01%	8300
2023 Q3	–	Sell	-14,420	Closed	-$593K	–	12416
2023 Q2	$593K	Buy	14,420 +4,994	+53%	+$240K	﹤0.01%	7909
2023 Q1	$541K	Sell	9,426 -2,380	-20%	-$134K	﹤0.01%	8393
2022 Q4	$662K	Buy	+11,806	New	+$601K	﹤0.01%	7152
2022 Q3	–	Sell	-20,978	Closed	-$1.07M	–	13601
2022 Q2	$1.13M	Buy	20,978 +15,227	+265%	+$914K	﹤0.01%	6222
2022 Q1	$370K	Sell	5,751 -3,193	-36%	-$210K	﹤0.01%	9739
2021 Q4	$599K	Buy	8,944 +5,649	+171%	+$382K	﹤0.01%	8689
2021 Q3	$226K	Buy	+3,295	New	+$233K	﹤0.01%	11212
2020 Q3	–	Sell	-14,862	Closed	-$707K	–	10792
2020 Q2	$698K	Buy	+14,862	New	+$731K	﹤0.01%	6663
2020 Q1	–	Sell	-4,496	Closed	-$236K	–	10515
2019 Q4	$262K	Buy	+4,496	New	+$268K	﹤0.01%	8265
2019 Q1	–	Sell	-70,659	Closed	-$3.6M	–	9286
2018 Q4	$3.19M	Sell	70,659 -99,661	-59%	-$5.47M	﹤0.01%	2853
2018 Q3	$11.2M	Sell	170,320 -18,859	-10%	-$1.17M	﹤0.01%	1816
2018 Q2	$12.2M	Buy	189,179 +176,523	+1,395%	+$10.9M	﹤0.01%	1742
2018 Q1	$700K	Sell	12,656 -30,676	-71%	-$1.61M	﹤0.01%	5955
2017 Q4	$2.07M	Buy	43,332 +13,231	+44%	+$648K	﹤0.01%	3847
2017 Q3	$1.52M	Sell	30,101 -13,465	-31%	-$692K	﹤0.01%	4434
2017 Q2	$2.38M	Buy	43,566 +5,298	+14%	+$253K	﹤0.01%	3592
2017 Q1	$1.61M	Sell	38,268 -121,576	-76%	-$5.19M	﹤0.01%	4121
2016 Q4	$6.86M	Buy	159,844 +123,356	+338%	+$5.01M	﹤0.01%	1985
2016 Q3	$1.51M	Buy	36,488 +19,202	+111%	+$804K	﹤0.01%	4038
2016 Q2	$690K	Sell	17,286 -48,510	-74%	-$1.75M	﹤0.01%	5552
2016 Q1	$2.22M	Buy	65,796 +21,468	+48%	+$669K	﹤0.01%	3586
2015 Q4	$1.5M	Sell	44,328 -26,272	-37%	-$821K	﹤0.01%	4617
2015 Q3	$2.1M	Sell	70,600 -23,533	-25%	-$736K	﹤0.01%	4178
2015 Q2	$2.59M	Sell	94,133 -42,625	-31%	-$1.14M	﹤0.01%	4146
2015 Q1	$3.45M	Buy	136,758 +21,470	+19%	+$508K	﹤0.01%	3305
2014 Q4	$2.56M	Buy	115,288 +64,891	+129%	+$1.32M	﹤0.01%	3997
2014 Q3	$1.02M	Sell	50,397 -18,322	-27%	-$365K	﹤0.01%	5874
2014 Q2	$1.32M	Buy	+68,719	New	+$1.28M	﹤0.01%	5461
2014 Q1	–	Sell	-14,307	Closed	-$276K	–	9114
2013 Q4	$279K	Buy	+14,307	New	+$262K	﹤0.01%	7696
2013 Q3	–	Sell	-28,262	Closed	-$423K	–	8556
2013 Q2	$423K	Buy	+28,262	New	+$414K	﹤0.01%	6292

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group's IART Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Integra LifeSciences (IART) in Q1 2026: 25,745 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #11332 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in IART as recently as Q3 2025.

Susquehanna International Group first reported a position in IART in Q2 2013 and has held it in 39 quarters since. The position peaked at $12.2M in Q2 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Susquehanna International Group held 25,745 shares of Integra LifeSciences worth $243K as of Q1 2026.
Integra LifeSciences was a new Susquehanna International Group position in Q1 2026.
Integra LifeSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11332 holding.
Susquehanna International Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 39 quarters since.
Susquehanna International Group's Integra LifeSciences position peaked at $12.2M in Q2 2018.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.